Criminal pricing of Merck's HIV/AIDS drug Isentress challenged by the AIDS Healthcare Foundation

Links shared publicly online about this topic.

1,776
total visits

Criminal pricing of Merck's HIV/AIDS drug Isentress challenged by the AIDS Healthcare Foundation

As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) today unveiled its latest advocacy campaign challenging Merck and Co. Pharmaceuticals over the steep price of its key HIV/AIDS drug, Isentress (raltegravir). The first phase of the public awareness campaign includes a postcard mailer, scheduled to arrive this week in the mailboxes of residents of Whitehouse Station, New Jersey, where Merck is headquartered.

View full resource at news-medical.net

Tags: AIDS, HIV Medication, STD, Drug, Healthcare, Pharma, Isentress, Merck & Co.